Cite
HARVARD Citation
Nishikawa, K. et al. (2018). A randomised phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: Capecitabine plus cisplatin ascertainment versus S-1 plus cisplatin randomised PII trial (XParTS II). European journal of cancer. pp. 220-228. [Online].